captopril has been researched along with losartan potassium in 21 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (14.29) | 18.7374 |
| 1990's | 11 (52.38) | 18.2507 |
| 2000's | 3 (14.29) | 29.6817 |
| 2010's | 3 (14.29) | 24.3611 |
| 2020's | 1 (4.76) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bailey, RR; Lewis-Barned, NJ; Livesey, J; Pratt, MC; Shand, BI; Walker, RJ | 1 |
| Frenken, LA; Koene, RA; Sluiter, HE; Wetzels, JF | 1 |
| Fliser, D; Nowack, R; Ritz, E | 1 |
| Fujishima, M; Motomura, K; Onoyama, K; Sanai, T | 1 |
| Barone-Varelas, J; Fried, W; Morley, C | 1 |
| DeWolf, R; Goodman, S; Gould, AB; Onesti, G; Swartz, C | 1 |
| Alcazar, JM; Andrés, A; Fernández, G; Hernández, E; Morales, JM; Ortuño, B; Praga, M; Rodicio, JL | 1 |
| Egeblad, M; Eiskjaer, H; Jensen, JD; Madsen, B; Nielsen, CB; Pedersen, EB | 1 |
| Walter, J | 1 |
| Aronoff, GR; Brier, ME; Bunke, CM; Lathon, PV | 1 |
| Holland, M; Shapiro, W; Stobie, D | 1 |
| Hess, E; Sperschneider, H; Stein, G | 1 |
| Fujisaki, N; Ikeda, Y; Kuwahara, M; Ohtsuka, Y; Sakemi, T | 1 |
| Freudenthaler, SM; Gleiter, CH; Körner, T; Schreeb, K | 1 |
| Falkay, G; Gaspar, R; Resch, BE; Sonkodi, S | 1 |
| Agharazii, M; Larivière, R; Lebel, M; Rodrigue, ME | 1 |
| Anker, SD; Belonje, AM; Dickstein, K; Ponikowski, P; van Veldhuisen, DJ; von Haehling, S; Voors, AA; Westenbrink, BD | 1 |
| Barshishat-Kupper, M; Davis, TA; Day, RM; Landauer, MR; McCart, EA; Mungunsukh, O; Panganiban, RA; Tipton, AJ | 1 |
| Barshishat-Kupper, M; Davis, TA; Day, RM; Landauer, MR; McCart, EA; Tipton, AJ | 1 |
| Bouten, RM; Bylicky, MA; Day, RM; Di Pucchio, T; Du, Y; Gudmundsson, KO; Lee, SH; McCart, EA; Muir, JM; Mungunsukh, O; Olsen, CH; Rittase, WB; Slaven, JE; Wilkins, WL | 1 |
5 trial(s) available for captopril and losartan potassium
| Article | Year |
|---|---|
Effect of angiotensin converting enzyme inhibitors on erythropoietin concentrations in healthy volunteers.
Topics: Adult; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Erythropoietin; Hematologic Tests; Humans; Male; Middle Aged; Renin-Angiotensin System; Single-Blind Method | 1992 |
Evidence for renal vasodilation in pre-dialysis patients during correction of anemia by erythropoietin.
Topics: Adult; Aged; Anemia; Captopril; Dialysis; Erythropoietin; Female; Humans; Kidney; Male; Middle Aged; Recombinant Proteins; Renal Circulation; Vasodilation | 1992 |
Worsening of anemia by angiotensin converting enzyme inhibitors and its prevention by antiestrogenic steroid in chronic hemodialysis patients.
Topics: Androstanols; Anemia; Angiotensin-Converting Enzyme Inhibitors; Captopril; Enalapril; Erythropoiesis; Erythropoietin; Estrogen Antagonists; Humans; Kidney Failure, Chronic; Middle Aged; Renal Dialysis; Renin-Angiotensin System | 1989 |
Usefulness and safety of treatment with captopril in posttransplant erythrocytosis.
Topics: Captopril; Creatinine; Erythropoietin; Female; Follow-Up Studies; Hematocrit; Hemoglobins; Humans; Kidney Transplantation; Male; Nifedipine; Polycythemia; Postoperative Complications; Potassium; Time Factors | 1995 |
Angiotensin II increases erythropoietin production in healthy human volunteers.
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Captopril; Erythropoietin; Heart Rate; Hematocrit; Hemoglobins; Hemorrhage; Humans; Infusions, Intravenous; Losartan; Male; Phlebotomy; Placebos | 1999 |
16 other study(ies) available for captopril and losartan potassium
| Article | Year |
|---|---|
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Current therapy of chronic kidney insufficiency].
Topics: Antihypertensive Agents; Captopril; Combined Modality Therapy; Diet, Sodium-Restricted; Dietary Proteins; Erythropoietin; Humans; Hypertension; Kidney Failure, Chronic; Recombinant Proteins | 1991 |
Factors that regulate extrarenal erythropoietin production.
Topics: Angiotensin II; Animals; Captopril; Carbon Tetrachloride Poisoning; Colchicine; Erythropoiesis; Erythropoietin; Female; Indomethacin; Kinetics; Liver; Nephrectomy; Organ Specificity; Rats; Rats, Inbred Strains; Uremia | 1984 |
Interrelation of the renin system and erythropoietin in rats.
Topics: Angiotensin I; Angiotensin II; Animals; Captopril; Erythropoietin; Female; Hypoxia; Male; Rats; Renin | 1980 |
Effect of captopril on the renal veno-arterial gradient of erythropoietin and oxygen in unilateral renal artery disease.
Topics: Adult; Aged; Captopril; Erythropoietin; Female; Humans; Male; Middle Aged; Oxygen; Renal Artery; Renal Artery Obstruction; Renal Veins | 1993 |
Does captopril decrease the effect of human recombinant erythropoietin in haemodialysis patients?
Topics: Captopril; Drug Interactions; Erythropoietin; Humans; Middle Aged; Recombinant Proteins; Renal Dialysis | 1993 |
Erythropoietin-induced antinatriuresis mediated by angiotensin II in perfused kidneys.
Topics: Angiotensin II; Angiotensin Receptor Antagonists; Animals; Biphenyl Compounds; Captopril; Dose-Response Relationship, Drug; Erythropoietin; Imidazoles; In Vitro Techniques; Kidney; Losartan; Male; Natriuresis; Perfusion; Rats; Rats, Wistar; Tetrazoles | 1993 |
Pancytopenia associated with administration of captopril to a dog.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Biopsy, Needle; Blood Cell Count; Bone Marrow; Captopril; Chronic Disease; Dog Diseases; Dogs; Erythropoietin; Granulocyte Colony-Stimulating Factor; Hematocrit; Male; Mitral Valve Insufficiency; Pancytopenia; Recombinant Proteins | 1996 |
Do ACE inhibitors influence the dose of human recombinant erythropoietin in dialysis patients?
Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Captopril; Dose-Response Relationship, Drug; Drug Interactions; Drug Therapy, Combination; Enalapril; Erythropoietin; Female; Follow-Up Studies; Fosinopril; Hematocrit; Humans; Hypertension; Kidney Failure, Chronic; Male; Recombinant Proteins; Renal Dialysis; Retrospective Studies | 1996 |
Drug-related low responsiveness to recombinant human erythropoietin therapy in three patients with end-stage renal disease.
Topics: Aged; Allopurinol; Anemia; Captopril; Drug Interactions; Drug Resistance; Erythropoietin; Female; Humans; Kidney Failure, Chronic; Male; Middle Aged; Piperidines; Recombinant Proteins | 1997 |
Vasoactive effects of erythropoietin on human placental blood vessels in vitro.
Topics: Adult; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Arteries; Captopril; Dose-Response Relationship, Drug; Erythropoietin; Female; Humans; In Vitro Techniques; Losartan; Placental Circulation; Pregnancy; Receptor, Angiotensin, Type 1; Recombinant Proteins; Vasoconstriction; Vasoconstrictor Agents; Veins | 2003 |
Antihypertensive and renal protective effects of renin-angiotensin system blockade in uremic rats treated with erythropoietin.
Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Blood Pressure; Body Weight; Captopril; Disease Models, Animal; Drug Therapy, Combination; Erythropoietin; Hydralazine; Hydrochlorothiazide; Hypertension; Kidney; Kidney Failure, Chronic; Losartan; Nephrectomy; Rats; Rats, Wistar; Recombinant Proteins; Renin-Angiotensin System; Reserpine; Time Factors; Uremia | 2006 |
Erythropoietin levels in heart failure after an acute myocardial infarction: determinants, prognostic value, and the effects of captopril versus losartan.
Topics: Aged; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Captopril; Erythropoietin; Female; Heart Failure; Humans; Losartan; Male; Myocardial Infarction; Prognosis; Retrospective Studies | 2009 |
Captopril modulates hypoxia-inducible factors and erythropoietin responses in a murine model of total body irradiation.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Basic Helix-Loop-Helix Transcription Factors; Captopril; Cell Differentiation; Cell Proliferation; Erythroid Precursor Cells; Erythropoietin; Female; Gamma Rays; Gene Expression Regulation; Mice; Thrombopoietin; Time Factors; Whole-Body Irradiation | 2011 |
Enhanced hematopoietic protection from radiation by the combination of genistein and captopril.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Cell Survival; Cells, Cultured; Drug Therapy, Combination; Erythrocytes; Erythropoietin; Female; Genistein; Hematopoiesis; Hematopoietic Stem Cells; Humans; Mice; Mice, Inbred C57BL; Radiation Injuries, Experimental; Radiation-Protective Agents; Whole-Body Irradiation | 2013 |
Effects of captopril against radiation injuries in the Göttingen minipig model of hematopoietic-acute radiation syndrome.
Topics: Acute Radiation Syndrome; Animals; Captopril; Disease Models, Animal; Erythropoietin; Gene Expression Regulation; Granulocyte-Macrophage Colony-Stimulating Factor; Hematopoietic System; Humans; Leukocytes, Mononuclear; Mice; Oxidation-Reduction; Radiation Injuries, Experimental; Swine; Swine, Miniature; Whole-Body Irradiation | 2021 |